Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ACTINOMYCIN”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 289 records · Page 16Linked to original sources

Inhibition of host protein synthesis by vaccinia virus: fate of cell mRNA and synthesis of small poly (A)-rich polyribonucleotides in the presence of actinomycin D.

Purified vaccinia virus rapidly inhibited HeLa cell protein synthesis in the presence of actinomycin D. Under these conditions host polyribosomes were extensively degraded but the mRNA was stable as indicated by a greater than 90% recovery of prelabeled polyadenylylated RNA. Although actinomycin D prevented the synthesis of host mRNA and poly(A) in uninfected cells, incorporation of adenosine into poly(A) was inhibited by less than 50% in infected cells. Further analysis indicated that there was little or no normal size viral mRNA but that a unique class of small poly(A)-rich RNA was made in the presence of actinomycin D. From measurements of the RNase resistance and base composition of the RNA, approximately 40% of the nucleotide sequence was estimated to be poly(A). The poly(A)-rich RNA was found associated with small polyribosomes and monoribosomes that were inactive in protein synthesis. It was suggested that the poly(A) segment of the RNA is formed by the poly(A) polymerase previously found in vaccinia virus cores and that the inactive RNA, by competing with host mRNA, may contribute to the virus-mediated inhibition of host protein synthesis observed in the presence of actinomycin D.

Adenine Nucleotides↗

Actinomycin D affects thyrotropin-releasing hormone-induced heterogeneous forms of glycosylated thyroid-stimulating hormone in rat anterior pituitary.

Actinomycin D and cycloheximide were used to clarify the tight relationship between protein synthesis and heterogeneous carbohydrate synthesis of rat pituitary thyroid-stimulating hormone (TSH) under thyrotropin-releasing hormone (TRH) stimulation in vitro. Rat anterior pituitaries were incubated with [3H]glucosamine in the presence of TRH, cycloheximide and actinomycin D at 37 degrees C for 3 and 6 h. The TSH fraction of pituitary homogenates was obtained using affinity chromatography coupled with anti-TSH globulin, and was analyzed by isoelectric focusing. Anterior pituitary in the presence of TRH showed heterogeneous components of [3H]glucosamine-labeled TSH with 6 different isoelectric points (components I-VI). Radioactivities of the components increased with the incubation period. Cycloheximide changed these heterogeneous components. Actinomycin D also caused a striking change in the heterogeneity of pituitary [3H]glucosamine-labeled TSH: components I and II decreased and components III and IV increased as compared to the control group after a 6-hour incubation. The present study implies that actinomycin D affects the TRH-induced heterogeneous components of pituitary TSH glycosylation. The data indicate that messenger RNA is essential for the normal processing of carbohydrate synthesis of pituitary TSH.

Animals↗

Dihydroorotic acid dehydrogenase activity in actinomycin-D-treated and normal chick embryos.

The effect of actinomycin D on chick embryos cultivated in vitro by New's culturing method was studied. Exposure of chick embryos to actinomycin D (0.05 micrograms/ml) at the primitive streak stage (stage 4; Hamburger and Hamilton) for 6 h showed interference in orotic acid formation. The assay of the enzyme dihydroorotic acid dehydrogenase was carried out in both treated and control embryos. No enzymic activity was observed in actinomycin-D-treated embryos in contrast to the considerable activity in the controls. These observations suggest an interference by actinomycin D in the biogenesis of the enzyme dihydroorotic acid dehydrogenase.

Animals↗

Actinomycin D blocks the hepatic functional albumin mRNA increase in aminonucleoside-nephrotic rats.

Hepatic functional albumin-mRNA was measured in the following groups of rats: (a) puromycin aminonucleoside (PAN)-nephrotic rats, (b) PAN-nephrotic rats treated with actinomycin D prior to sacrifice, (c) control rats, and (d) control rats treated with actinomycin D. Albumin mRNA was translated in an mRNA-dependent cell-free system from rabbit reticulocyte lysate. Albumin-mRNA increased about 2-fold in PAN-nephrotic rats. This increase was abolished in vivo in PAN-nephrotic rats treated with actinomycin D. Albumin mRNA was not significantly modified in control rats treated with actinomycin D. These data suggest that the increased level of hepatic functional albumin mRNA observed in PAN-nephrotic rats in vivo was due mainly to the increased rate of albumin gene transcription.

Albumins↗

Actinomycin D revisited in testicular cancer. A case report.

BACKGROUND: Between 20-30% of patients with advanced germ cell tumors relapse or fail to achieve a complete response to conventional cisplatin based chemotherapy. Ifosphamide has been used very effectively in combination with cisplatin and etoposide (VIP) or in combination with cisplatin and vinblastine (VeIP). Actinomycin D with chlorambucil and methotrexate was widely used in the 1960s with complete responses in 20% of patients and long term survival of 6-10%. There exists no information on the use of actinomycin as a salvage in cisplatin refractory patients. METHODS AND RESULTS: One patient with metastatic germ cell tumor who failed chemotherapy with cisplatin and ifosphamide was successfully treated with an actinomycin D based regimen. CONCLUSIONS: Actinomycin D is an active agent in testicular cancer and maybe used in patients refractory to platinum.

Adult↗

Inhibition of RNA synthesis by acetyl salicylate and actinomycin D during early development in the mouse.

Experiments were designed to ascertain and compare the effects of acetyl salicylate and actinomycin D on RNA synthesis in mouse oocytes in vitro and in vivo. After exposure to the drugs the effects on RNA synthesis were measured by incorporation of [3H]uridine and autoradiography. The results indicate that acetyl salicylate inhibits RNA synthesis in the treated oocytes as does actinomycin D. The only difference in the effects of these two drugs is that salicylate inhibits RNA synthesis to a much lesser degree than does actinomycin D. Effects from a short exposure to salicylate may be reversible; the same effects with actinomycin D cannot be reversed. In utero exposure of the female fetus may lead to partial or total sterility (depending on the dose and time of exposure) of that fetus and/or abnormal development of the progeny from those mice (F2). These results suggest that RNA synthesis in early oogenesis is a vital part of later development of the oocytes in adult mouse ovary. Inhibition of RNA may be one of the causes of malformations and sterility.

Animals↗

Induction of fetal rat enterokinase (enteropeptidase EC. 3.4.21.9) in utero by hydrocortisone and actinomycin D.

Enterokinase activity is first detected in the small intestine of the rat at the 20th day of gestation, whereas sucrase activity first appears in the 14th day of postnatal life. Intraperitoneal injection of hydrocortisone to pregnant rats before the normal appearance of enterokinase in fetuses causes the premature appearance of enterokinase (58 +/- 8 units), but not of sucrase activity. The addition of actinomycin D in the pregnant rat results in supermaximal stimulation of enterokinase activity (229 +/- 25 units). Sucrase activity is stimulated by hydrocortisone when given in the first 3 days of life (118 +/- 0.04 units). The maximal induction occurs 2 days before the normal appearance of the enzyme in untreated animals (7.3 +/- 12 units). The addition of actinomycin D diminished the effect of hydrocortisone on sucrase activity in the neonatal rat (1.4 +/- 2 units versus 1.8 +/- 0.4 units in 3-day-old rats). Thus, enterokinase and sucrase of the small intestine of the fetal and infant rat respond differently to combined hydrocortisone and actinomycin D. The response to hydrocortisone is age dependent and the maximal induction occurs before the time of the natural appearance of the enzymes. No effect is elicited after the normal appearance of enterokinase or sucrase. Glucocoticoids stimulate an early appearance of small intestinal enzymes only before the expected time of the natural development burst of activity. In both, sucrase and enterokinase, glucocorticoids have no effect after the enzymes are fully developed. New enzymes develop in clusters during the late fetal, neonatal, and late sucking periods. The effect of glucocorticoids on the "maturation" of the small intestine is limited to the induction of one phase only; i.e., only before the late fetal period is the precocious appearance of enterokinase possible. The induction of enterokinase activity can serve as an indicator for the early phase of maturation. Whereas the induction of sucrase activity can serve as a marker for late phase of maturation of the small intestine in the rat. The superinduction of enterokinase, but not of sucrase activity, by the addition of actinomycin D to glucocorticoids might be related to the different stability of the mRNA's of these enzymes.

Age Factors↗

Protactin, a new antibiotic metabolite and a possible precursor of the actinomycins.

Streptomyces cucumerosporus strain L703-4 (ATCC 53784) produces a new 4-methyl-3-hydroxyanthraniloylpentapeptide lactone for which we have proposed the name protactin, in addition to several actinomycin components. Protactin is rather resistant to air oxidation but it can be converted to a new actinomycin, actinomycin Zp by ferricyanide oxidation. Actinomycin Zp possesses in vitro antibacterial activity and in vivo antitumor activity against P-388 leukemia in mice.

Amino Acid Sequence↗

Prophylactic actinomycin D for high-risk complete hydatidiform mole.

OBJECTIVE: To evaluate the effectiveness of one course of prophylactic actinomycin D in reducing the malignant sequelae requiring chemotherapy in high-risk complete hydatidiform mole (CHM). STUDY DESIGN: A double-blind, randomized, controlled clinical trial was carried out at King Chulalongkorn Memorial Hospital. Sixty cases of CHM classified as high risk were recruited and randomly allocated to a chemoprophylactic or control group. Within one week after evacuation of molar tissues, actinomycin D was administered in the chemoprophylactic group. Patients in the control group were given only intravenous fluid and analgesic drugs. The number of patients with malignant sequelae who required therapeutic chemotherapy after evacuation of hydatidiform mole in each group was recorded. RESULTS: The incidence of malignant sequelae was 13.8% (95% confidence interval [CI] = 3.9-31.7%) in the chemoprophylactic group and 50.0% (95% CI = 31.3-68.7%) in the control group. The risk reduction of malignant sequelae with one course of actinomycin D chemoprophylaxis in high-risk CHM was 72.4% (95% CI = 26.7-89.6%) (P = .005). The side effects of prophylactic chemotherapy were stomatitis, nausea/vomiting, sore throat with oral ulcer and hair loss. CONCLUSION: One course of actinomycin D given as chemoprophylaxis decreased by 72.4% malignant sequelae after evacuation of molar tissue in patients with high-risk CHM. This may be particularly beneficial in patients with high-risk CHM who cannot be followed closely, whose compliance is in question and for whom hormonal follow-up is not available or unreliable.

Adolescent↗

Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival.

The possibility of employing liposome-entrapped actinomycin D for the treatment of AKR mice inoculated with AKR-A cells was examined. It was found that injection of actinomycin D after its entrapment in liposomes prolonged the survival of such mice to a greater extent than did similar amounts of free actinomycin D. Data from in vitro experiments suggest that entrapped actinomycin D could localize in the nucleus of AKR-A cells presumably following endocytosis of the liposomal carrier and subsequent liberation of the drug in, and its diffusion from, the lysosomes.

Animals↗

[Effect of actinomycin D on cell proliferation induced by phytohemagglutinin in human lymphocytes].

Actinomycin D at a dose inhibiting the synthesis of ribosomal RNA (0.15 MUG/ML) BLOCKS THE TRANSITION OF CELLS INTO ACTIVE PROLIFERATION DURING THE FIRST 6 HOURS AFTER PHYTOHAEMAGGLUTININ TREATMENT. The effect of actinomycin D becomes weaker as the cells proceed through the prereplicative period. 1 mug/ml actinomycin D blocks the synthesis of all RNSs. It has been found that actinomycin D at this concentration blocks the transition of cells into the proliferation during the entire prereplicative period.

Amino Acids↗

[Effect of actinomycin D on RNA synthesis in a stationary culture of Chinese hamster cells stimulated to proliferate].

The study of the effects of actinomycin D on stationary cultures of Chinese hamster cells and those stimulated by medium changing has revealed that RNA synthesis is more sensitive in the latter, the difference in the first place being attributed to the rate of labeled uridine incorporation into cell nucleoli. There is no significant difference in H3-actinomycin D uptake between stationary and stimulated cells, but the latter incorporate more labeled actinomycin D into their nuclei. A pronounced variation in sensitivity to actinomycin D is observed during the prereplicative period of stimulated cells. The first part of this period is more sensitive, which may be due to the necessity for stimulated cells to synthesize a great number of ribosomes to enter the mitotic cycle and to proceed through it.

Animals↗

Altered subcellular distribution of nucleolar protein fibrillarin by actinomycin D in HEp-2 cells.

AIM: To study the effects of actinomycin D on subcellular distribution of nucleolar protein fibrillarin in HEp-2 (human esophageal epithelial type 2) cells, and molecular mechanisms for maintenance of fibrillarin in nucleolus. METHODS: Indirect immunofluorescence assay was employed to investigate subcellular distribution of nucleolar protein fibrillarin and immunoblotting analysis was used to detect the total cellular amount of fibrillarin. RESULTS: Control cells with no drug treatment showed bright clumpy nucleolar staining, which indicated that fibrillarin decorated the nucleolus only. Treatment with actinomycin D caused dislocation of fibrillarin from nucleoli to nucleoplasm with numerous stained small nucleoplasmic entities. Immunoblotting showed that neither total cellular amount of fibrillarin nor the integrity of fibrillarin was changed upon the treatment. The dislocation of fibrillarin in cells treated at a lower concentration (0.05 mg/L) of actinomycin D, was totally reversible after removal of the drug from the medium. However, this reversion was not observed at a high drug concentration (1 mg/L). CONCLUSION: Actinomycin D induced dislocation of fibrillarin from nucleoli to nucleoplasm in HEp-2 cells. The retention of fibrillarin within the nucleolus was related to active RNA synthesis.

Cell Nucleolus↗

[Investigation of cell wall components in actinomycin D resistant Staphylococcus aureus].

Cell walls in 2 strains of Staphylococcus aureus 209P, i.e. actinomycin D susceptible and resistant ones were comparatively investigated. The resistant cells contained much more wall material per a unit of the biomass weight vs the susceptible strain cells, that conformed to thickening of the resistant cell walls detected by electron microscopy and a sharp increase of their electron density. Investigation of peptidoglycans and teichoic acids did not reveal any significant alterations in the structure of the wall components in the actinomycin D resistant cells. Only some increase of glucosamine in the peptidoglycan fraction of the resistant cells vs the susceptible ones was observed. It was shown that preparations of the resistant cell walls and peptidoglycan isolated from the resistant cells were able to bind somewhat lower quantities of actinomycin D vs the analogous preparations of the susceptible cells. The significant decrease of the antibiotic binding by live cells of the resistant strain probably slightly depended on the structure characteristics of the main wall components. The barrier properties of the walls in resistant staphylococci are most likely defined by the wall thickening and consolidation while adapting to actinomycin D.

Cell Wall↗

Tri-iodo thyronine regulates antioxidant enzyme activities in different cell fractions through a mechanism sensitive to actinomycin D in a teleost, Anabas testudineus (Bloch).

The present study evaluated the effects of hyperthyroid state on lipid peroxidation and antioxidant enzymes in the crude (CF), post nuclear (PNF) and mitochondrial fractions (MF) of the fish liver. The in vivo injection of T3 (200ng) did not change the lipid peroxidation products, malondialdehyde (MDA) and conjugated dienes (CD), while actinomycin D (10microg), a potent mRNA inhibitor when administered with T3 increased them. The antioxidant enzymes like superoxide dismutase (SOD) and catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase (GR) had an increased activity in CF and MF of hyperthyroid group to compete the increased oxidative stress, but actinomycin D partially inhibited the T3-induced activity. SOD and CAT activities in PNF of hyperthyroid group had no change, the glutathione concentration varied depending on the GPx and GR activity. Hyperthyroidism decreased the protein content, while simultaneous administration of actinomycin D inhibited the T3 action of elevating the protein content. The results suggest that the antioxidant defense status in A. testudineus is modulated by thyroid hormone, through an action sensitive to actinomycin D.

Animals↗

Mechanism of actinomycin D-induced resistance in Ridgway osteogenic sarcoma: an ultrastructural study.

The ultrastructural appearances of actinomycin D treated sensitive and resistant sublines of Ridgway osteogenic sarcoma (ROS) have been correlated with the suggested mechanism of drug-induced resistance. The resistant subline (designated ROS/ADX/G2) was developed by repeated suboptimal treatment of tumor bearing animals and passage of the fastest growing tumors. In the present experiments, animals bearing sensitive and resistant tumors were given a single intraperitoneal injection of actinomycin D (0.3 microgram/g) and examined at 1, 6 and 24 h after injection. The principal effect of actinomycin D treatment in both cell lines was the development of nucleolar segregation. This change, however, followed a different time-scale in each case, appearing more prominently at an early stage and returning more quickly to normal in the actinomycin D resistant cell line. These findings can be interpreted as being in agreement with the suggestion that reduced drug retention or an increased rate of detoxification provides the mechanism of acquired resistance.

Animals↗

[Effect of actinomycin D on the formation of the photoreceptor ultrastructure of the retina in the chick embryo].

The influence of actinomycin D on the ultrastructure of retina photoreceptors in 10, 11 and 12 day old chick embryos was studied. Actinomycin D was shown to provoke certain changes in the ultrastructure of differentiating retina visual cells as soon as 1 hour after injection. These changes involve segregation and diffusion of nucleoli, changes in mitochondrial matrix, destruction of their external membranes and cristae, changes in the diameter and length of canals of endoplasmic reticulum, disintegration of polysomes. The noted changes do not prevent a further differentiation of the internal segments - ellipsoid and paraboloid of visual cells, but considerably affect parametres of these organelles. The formation of membrane disks of photoreceptors is inhibited after a 24 hours incubation with the inhibitor, when actinomycin D was injected to 11 day old embryos. Injection of actinomycin D into 12 day old chick embryos, after a 24 hours incubation with the inhibitor, does not inhibit a formation of membrane disks of photoreceptors, but somewhat retards their differentiation. This effect may be associated with the transcription o mRNA for protein synthesis of the membrane disks, which presumably takes place on the 11th day of the chick embryo incubation.

Animals↗

Ultrastructural changes in immature chick oviduct epithelium during avidin induction by actinomycin D.

Avidin induction by actinomycin D may be mediated through cell damage. So the morphology of chick oviduct epithelium was studied 0-24 h after administration of actinomycin D (0.2 mg/kg, i.p.). The avidin content of the oviducts was measured by radioimmunoassay. There were several changes indicating cell damage in both the cytoplasm and nucleus. Marked vesiculation in and around Golgi complexes and the appearance of groups of light vacuoles occurred within 7 h of treatment. Swelling and breakage of mitochondria were found, the perinuclear cleft was enlarged and autophagosomes developed after 12 h. Invagination and swelling of the nucleus occurred during the experimental period. An increase in nuclear pores, polysomes and rough endoplasmic reticulum probably reflected the reparative processes of the cells. Ne secretory granules could be seen. Avidin accumulation began 7 h after actinomycin D, beginning simultaneously with the cell damage and earlier than the marks of regeneration. It is concluded that the avidin induced by actinomycin D is implicated in the severe cell damage caused by the drug.

Animals↗